RARE vs STEP · rev $560.2M vs rev $1.99B
Ultragenyx (RARE) versus Stepstone Group Inc (STEP) — a side-by-side from cached financials, not a winner call.
Ultragenyx (RARE) is a biotechnology company listed on US.
Stepstone Group Inc (STEP) is a asset management company listed on NASDAQ.
Latest reported RARE revenue for 2024-12-31 was $560.2M. Net income was -$569.2M. Revenue was up 29.0% from 2023-12-31 to 2024-12-31. RARE currently screens at market cap $2.79B.
Latest reported STEP revenue for 2026-03-31 was $1.99B. Net income was -$535.8M. Revenue was up 69.7% from 2025-03-31 to 2026-03-31. STEP currently screens at market cap $5.78B.
RARE currently screens at market cap $2.79B. STEP currently screens at market cap $5.78B.
Not investment advice. Open the RARE and STEP stock pages for the full models.
Not investment advice.